Cryo-Cell International to Present at the Q3 Virtual Investor Summit

August 11, 2021 7:02 AM EDT

Oldsmar, Florida--(Newsfile Corp. - August 11, 2021) - Cryo-Cell International (OTC Pink: CCEL) today announced that David Portnoy, Chairman of the board and Co-CEO, will be attending the Q3 Virtual Investor Summit.

EventQ3 Investor Summit
DateAugust 17-18th, 2021
PresentationAugust 18th at02:45 PM ET
Locationhttps://zoom.us/webinar/register/WN_mUXIsyaBSl6hpoY8M7ZNpA

About Cryo-Cell International

Founded in 1989, Cryo-Cell International Inc., the worlds first private cord blood bank, is internationally recognized as the industry leader. More than 500,000 parents from 87 countries have entrusted Cryo-Cell International with their babys cord blood and cord tissue stem cells. Cryo-Cell aims to help more patients significantly improve their lives through the utilization of the unique immunomodulatory and potential regenerative properties found in the cord blood and cord tissue. In February 2021, Cryo-Cell entered into an exclusive, collaborative license agreement with Duke University that grants Cryo-Cell the rights to intellectual property, proprietary processes and regulatory/clinical data related to cord blood and cord tissue developed at The Marcus Center for Cellular Cures at Duke University. Cryo-Cell is scheduled to open its first infusion clinic by 2022, to treat patients with conditions such as autism, cerebral palsy, and traumatic brain injuries under the rights granted to Duke University through the FDAs Expanded Access Program. In addition to these, the license agreement includes other clinical indications currently being studied, such as adult stroke, multiple sclerosis, osteoarthritis and COVID-19.Cryo-Cells mission is to provide clients with premier cord blood and cord tissue cryopreservation services, raise awareness of the opportunity for expectant parents to bank or donate their babys cord blood and support the advancement of regenerative medicine.

For further information:

Cryo-Cell International
Diane Glanz, PharmD, RPh
8137492195
[email protected]

About the Investor Summit

The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 80+ companies and over 800 investors, consisting of institutional investors, family offices, and private wealth.

To request complimentary investor registration: please click here: Complimentary Investor Registration

Contact:

Sasha Murray at [email protected]



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Newsfile, Press Releases

Related Entities

FDA